Mirion Technologies, Inc. (NYSE:MIR) Given Consensus Rating of “Moderate Buy” by Brokerages

Mirion Technologies, Inc. (NYSE:MIR) has earned a consensus rating of “Moderate Buy” from the eleven brokerages that are presently covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation, eight have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year price target among brokers that have issued a report on the stock in the last year is $25.5556.

MIR has been the subject of a number of recent research reports. Jefferies Financial Group started coverage on Mirion Technologies in a research note on Thursday, September 3rd. They set a “buy” rating and a $20.00 price target for the company. B. Riley Financial lowered their price target on Mirion Technologies from $29.00 to $27.00 and set a “buy” rating for the company in a research note on Thursday, July 30th. The Goldman Sachs Group restated a “buy” rating and issued a $23.00 price objective on shares of Mirion Technologies in a report on Wednesday, July 29th. Morgan Stanley cut their price objective on shares of Mirion Technologies from $27.00 to $25.00 and set an “equal weight” rating on the stock in a research report on Monday, July 13th. Finally, Citigroup reduced their target price on shares of Mirion Technologies from $28.00 to $24.00 and set a “buy” rating for the company in a research note on Thursday, July 30th.

Mirion Technologies Trading Up 2.5%

NYSE MIR opened at $16.24 on Friday. Mirion Technologies has a 1-year low of $14.11 and a 1-year high of $30.28. The company has a current ratio of 3.20, a quick ratio of 2.63 and a debt-to-equity ratio of 0.64. The company has a market capitalization of $4.04 billion, a PE ratio of 162.37 and a beta of 1.05. The firm’s fifty day simple moving average is $15.78 and its 200-day simple moving average is $17.67.

Mirion Technologies (NYSE:MIR) last released its quarterly earnings data on Tuesday, July 28th. The company reported $0.12 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.10 by $0.02. Mirion Technologies had a return on equity of 6.59% and a net margin of 2.39%.The firm had revenue of $266.80 million during the quarter, compared to analysts’ expectations of $269.32 million. During the same quarter last year, the firm earned $0.11 earnings per share. The business’s revenue for the quarter was up 19.7% on a year-over-year basis. Mirion Technologies has set its FY 2026 guidance at 0.480-0.550 EPS. As a group, sell-side analysts anticipate that Mirion Technologies will post 0.54 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Mirion Technologies

Institutional investors and hedge funds have recently modified their holdings of the business. Assetmark Inc. increased its position in Mirion Technologies by 8,123.8% during the first quarter. Assetmark Inc. now owns 3,454 shares of the company’s stock worth $64,000 after buying an additional 3,412 shares during the last quarter. Nykredit A S acquired a new stake in shares of Mirion Technologies in the second quarter worth about $137,000. Swiss Life Asset Management Ltd lifted its position in shares of Mirion Technologies by 10.4% in the fourth quarter. Swiss Life Asset Management Ltd now owns 10,856 shares of the company’s stock worth $254,000 after buying an additional 1,024 shares during the last quarter. SBI Okasan Asset Management Co.Ltd. bought a new stake in shares of Mirion Technologies during the 4th quarter worth about $261,000. Finally, Balefire LLC bought a new stake in shares of Mirion Technologies during the 2nd quarter worth about $226,000. Institutional investors and hedge funds own 78.51% of the company’s stock.

Mirion Technologies Company Profile

Mirion Technologies, Inc develops and provides radiation detection, measurement, and analysis solutions. Its products and services are used to monitor radiation, support nuclear safety, improve operational efficiency, and provide data for medical, industrial, scientific, and government applications.

The company’s offerings include radiation detectors, spectroscopy systems, dosimetry and personnel-monitoring solutions, radiation-monitoring equipment, and related software and services. In healthcare, Mirion provides technologies used in radiation therapy quality assurance, medical imaging, and radiation safety.